Non-essential drugs: NPPA withdraws price control order

September 24, 2014 12:42 am | Updated December 04, 2021 11:24 pm IST - NEW DELHI:

The National Pharmaceutical Pricing Authority] has withdrawn its order to fix prices of drugs

The National Pharmaceutical Pricing Authority] has withdrawn its order to fix prices of drugs

The National Pharmaceutical Pricing Authority (NPPA) has withdrawn its order to fix prices of drugs, which are not under the list of essential medicines, a move that has been welcomed by the pharmaceutical industry.

The NPPA had late on Monday issued a statement, saying it has withdrawn guidelines for price control issued under Para 19 of the Drug Prices Control Order (DPCO), 2013.

The Paragraph 19 of the DPCO, 2013, authorises the NPPA to control the prices drugs that are not under the NLEM (National List of Essential Medicines) under extraordinary circumstances in public interest. The NPPA had invoked Para 19 of the DPCO to cap prices of 108 medicines, including cardiac, diabetes and HIV/AIDS drugs, last month.

“In compliance with the directions received from the government in the Department of Pharmaceuticals...the aforesaid internal guidelines issued by the NPPA on May 29, 2014 under Paragraph 19 of DPCO 2013 are, hereby, withdrawn with immediate effect,” the NPPA said in a statement.

The order will be effective prospectively.

An NPPA official explained that the order meant that the powers the authority drew from the DPCO for fixing caps for non-essential drugs is no longer available.

“The plain reading of the order is that a guideline under DPCO 2013 has been withdrawn with immediate effect, that is, from September 22,” he said.

Several industry bodies, including the Indian Pharma Alliance (IPA), had criticised the NPPA’s move to cap the prices of medicines not under NLEM. Under the Drug Price Control Order (DPCO) 2013, the government already controls the prices of 348 drugs listed in the NLEM.

Top News Today

Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.